# Bioventus acquires Misonix

Misonix, a provider of minimally invasive therapeutic ultrasonic technologies, has been acquired by Bioventus. Misonix stockholders received either 1.6839 shares of Bioventus class A common stock or $28.00 in cash per share.

- Type: Acquisition
- Announced: 2021-10-01
- Where: Durham, North Carolina, United States
- Status: completed
- Products: ultrasonic technologies, regenerative medicine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Misonix](https://endata.com/companies/28191.md) (target)
- [Bioventus Inc.](https://endata.com/companies/54140.md) (acquirer)

## Sources

- [jonesday.com](https://www.jonesday.com/en/practices/experience/2021/10/misonix-merges-with-bioventus), 2021-10-01: "Misonix is a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical outcomes and Bioventus is a global leader in innovations for active healing."
- [bioventus.com](https://www.bioventus.com/bioventus-and-misonix-stockholders-approve-the-acquisition-of-misonix-by-bioventus/), 2021-10-26: "The combination with Misonix creates significant value and provides a deeper global portfolio of pain treatments, restorative therapies and surgical solutions for patients."
- [bioventus.com](https://www.bioventus.com/bioventus-completes-the-acquisition-of-misonix/), 2021-10-29: "The commercial reach of the new Bioventus is significantly broader, deeper and even more global."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.